Table 4.
0 d | 1 d | 3 d | 7 d | ||
---|---|---|---|---|---|
L* | NC | 60.87±2.22ay | 59.98±3.17ay | 59.75±2.25ay | 57.49±2.19ax |
PC | 61.45±1.65az | 59.27±1.39ay | 59.07±2.77ay | 55.61±2.73ax | |
15 BG | 60.76±2.39az | 58.16±2.08axy | 57.49±1.35ax | 59.64±1.87byz | |
30 BG | 59.54±2.30ax | 58.64±2.19ax | 57.76±3.36ax | 57.38±2.66ax | |
60 BG | 61.33±2.54ay | 60.34±3.90axy | 57.86±2.57ax | 57.90±2.81ax | |
a* | NC | 7.50±1.70ax | 7.14±1.52ax | 7.05±0.97ax | 8.43±2.01ax |
PC | 7.93±1.55ax | 8.27±1.22axy | 7.48±1.37abx | 9.29±1.44ay | |
15 BG | 7.83±1.14ax | 8.44±1.54ax | 7.54±2.06abx | 8.07±1.37ax | |
30 BG | 7.73±1.60ax | 8.31±0.98ax | 8.86±1.64bx | 8.44±2.11ax | |
60 BG | 8.72±1.45ax | 8.28±1.33ax | 8.54±1.53bx | 7.89±1.39ax | |
b* | NC | 12.14±1.72ax | 11.67±3.08ax | 10.75±0.93ax | 13.74±2.79ay |
PC | 13.32±2.68bx | 12.38±1.50ax | 12.98±2.14ax | 13.37±1.88ax | |
15 BG | 12.61±1.45ax | 12.38±2.32ax | 11.80±3.20ax | 14.09±3.11ax | |
30 BG | 11.87±1.42ax | 11.85±2.16ax | 12.81±3.24ax | 13.95±3.71ax | |
60 BG | 14.48±1.11by | 12.17±2.65ax | 12.59±1.87ax | 14.34±1.71ay |
Values are mean±standard deviation of each treatment group. n = 8.
NC, negative control; PC, positive control (adding Zinc bacitracin); 15 BG, adding 15 ppm β-glucan; 30 BG, adding 30 ppm β-glucan; 60 BG, adding 60 ppm β-glucan.
Statistically significant differences (p<0.05) between column.
Statistically significant differences (p<0.05) between incubation row.